Efficacy of adjuvant chemotherapy according to the classification of recurrence risk based on systemic inflammatory markers in patients with liver metastases of …

M Shibutani, H Nagahara, T Fukuoka, Y Iseki… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: Although complete resection of liver metastases colorectal cancer (CLM) is
the only potentially curative treatment, surgery alone is not enough, as the recurrence rate …

[HTML][HTML] Prognostic value of the C-reactive protein/albumin ratio and systemic immune-inflammation index for patients with colorectal liver metastasis undergoing …

Y Deng, Y Zhao, J Qin, X Huang, R Wu… - Pathology and …, 2021 - por-journal.com
Background: We evaluated the prognostic value of C-reactive protein/albumin (CAR) and
systemic immune-inflammation index (SII), which we calculated as neutrophil× …

[HTML][HTML] Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

NN Rahbari, C Reissfelder, H Schulze-Bergkamen… - BMC cancer, 2014 - Springer
Background Despite introduction of effective chemotherapy protocols, it has remained
uncertain, if patients with colorectal cancer (CRC) liver metastases should receive adjuvant …

Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver …

A Dupré, S Berhane, AWH Chan, M Rivoire… - European Journal of …, 2019 - Elsevier
Background This study aimed to create a new prognostic score integrating the systemic
inflammatory response to predict survival in patients treated with curative intent for colorectal …

The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C‐reactive protein (CRP) is a strong negative prognostic …

AH Køstner, C Kersten, T Löwenmark… - Journal of surgical …, 2016 - Wiley Online Library
Background and Objectives Systemic inflammation has been associated with poor survival
in several tumor types, but has been less extensively studied in resectable metastatic …

Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer

M Ishizuka, J Kita, M Shimoda… - Journal of surgical …, 2009 - Wiley Online Library
Background Few studies have investigated the Glasgow Prognostic Score (GPS) in patients
with liver metastases from colorectal cancer (LM‐CRC). Methods The GPS was calculated …

Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases

Y Sakamoto, K Mima, K Imai, Y Miyamoto, R Tokunaga… - Surgical Oncology, 2020 - Elsevier
Purpose Accumulating evidence suggests that the inflammatory tumor microenvironment
can potentiate tumor progression and metastasis. The C-reactive protein-to-albumin ratio …

[HTML][HTML] Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases

D Xu, YY Wang, XL Yan, J Li, K Wang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Preoperative chemotherapy has widely been used in colorectal cancer liver
metastasis (CRLM). Pathological response to chemotherapy is very important in evaluating …

Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis

Q Li, L Chen, H Jin, Y Zhao, Z Hao… - Clinical Medicine …, 2022 - journals.sagepub.com
Introduction: Pretreatment inflammatory markers were applied to predict the prognosis of
colorectal cancer. However, the role of these markers in predicting survival in patients with …

[HTML][HTML] Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis

W Toren, D Ansari, R Andersson - Cancer Cell International, 2018 - Springer
Background Many studies have investigated the prognostic role of biomarkers in colorectal
liver metastases (CRLM). However, no biomarker has been established in routine clinical …